Literature DB >> 15657920

Insight into hepatotoxicity: The troglitazone experience.

Paul B Watkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15657920     DOI： 10.1002/hep.20598

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  8 in total

Review 1.  Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.

Authors:  Raj Vuppalanchi; Naga Chalasani
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

Review 2.  Modulating peroxisome proliferator-activated receptors for therapeutic benefit? Biology, clinical experience, and future prospects.

Authors:  Robert S Rosenson; R Scott Wright; Michael Farkouh; Jorge Plutzky
Journal:  Am Heart J       Date:  2012-10-16       Impact factor: 4.749

3.  LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).

Authors:  Amanda Karolina Soares e Silva; Dilênia de Oliveira Cipriano Torres; Fabiana Oliveira dos Santos Gomes; Bruna dos Santos Silva; Edlene Lima Ribeiro; Amanda Costa Oliveira; Laise Aline Martins dos Santos; Maria do Carmo Alves de Lima; Ivan da Rocha Pitta; Christina Alves Peixoto
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

4.  Cloxiquine, a traditional antituberculosis agent, suppresses the growth and metastasis of melanoma cells through activation of PPARγ.

Authors:  Wenxiang Zhang; Wei Shao; Zhewen Dong; Shiyao Zhang; Chang Liu; Siyu Chen
Journal:  Cell Death Dis       Date:  2019-05-28       Impact factor: 8.469

5.  Effect of Microbial Short-Chain Fatty Acids on CYP3A4-Mediated Metabolic Activation of Human Pluripotent Stem Cell-Derived Liver Organoids.

Authors:  Seon Ju Mun; Jaeseo Lee; Kyung-Sook Chung; Mi-Young Son; Myung Jin Son
Journal:  Cells       Date:  2021-01-11       Impact factor: 6.600

6.  Fast Identification of Adverse Drug Reactions (ADRs) of Digestive and Nervous Systems of Organic Drugs by In Silico Models.

Authors:  Meimei Chen; Zhaoyang Yang; Yuxing Gao; Candong Li
Journal:  Molecules       Date:  2021-02-10       Impact factor: 4.411

7.  Cardiometabolic interventions - focus on transcriptional regulators.

Authors:  Joshua T Chai; Robin P Choudhury
Journal:  Eur J Cardiovasc Med       Date:  2013-08-13

8.  Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro.

Authors:  Deborah G Nguyen; Juergen Funk; Justin B Robbins; Candace Crogan-Grundy; Sharon C Presnell; Thomas Singer; Adrian B Roth
Journal:  PLoS One       Date:  2016-07-07       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.